SecBot SecBot
SC 13G/A ·Filed Nov 4, 2026

BMRN

BIOMARIN PHARMACEUTICAL INC
NEUTRAL
Impact 3/10
Horizonimmediate Processed12d 9h ago SEC0002012383-26-003968
Passive stake amendment
Actionable Insight • Neutral

BlackRock's passive stake increase to 10.0% is consistent with index fund rebalancing and does not signal activist intent. Monitor for any conversion to a 13D filing if BlackRock engages with management on strategy, particularly given BioMarin's recent guidance cut and acquisition-related charges.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$56.12
T+0 close · Nov 4, 2026 · via day close
Latest settled
+1.03%
T+5 · $56.70 · next T+20 in 17d
Vs SPY
−2.26%
α at T+5
Latest observation
+2.58%
T+6 · FF3 residual α
  1. T+0 · Nov 5 $56.12entry
  2. T+1 · 11d ago −0.16%α −0.47% · $56.03
  3. T+5 · 5d ago +1.03%α −2.26% · $56.70
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

BlackRock filed an amended Schedule 13G disclosing beneficial ownership of 19,373,309 shares of BioMarin common stock, representing 10.0% of shares outstanding as of October 31, 2026. This is an increase from the prior filing (Vanguard's April 2026 filing showed 18,549,911 shares at 10.0%), indicating BlackRock added approximately 823,398 shares. The filing is a routine passive stake update by a large index/asset manager, filed two days after BioMarin reported Q3 revenue up 32% YoY but lowered full-year guidance.

Key Financial Metrics

Stake
10%
Investor
BlackRock, Inc.
Investor Type
mutual fund

Key Facts

  • BlackRock reported beneficial ownership of 19,373,309 shares of BioMarin common stock as of October 31, 2026
  • Stake represents 10.0% of outstanding shares
  • BlackRock Fund Advisors is the entity that beneficially owns 5% or more of the class
  • This is an amendment to a prior Schedule 13G filing
  • The filing was made under Rule 13d-1(b) as a passive investor
  • BlackRock certifies the securities were acquired in the ordinary course of business and not to change or influence control

Financial Impact

BlackRock holds 19,373,309 shares, approximately 10.0% of BioMarin's outstanding stock, valued at roughly $1.1B based on the $11.1B market cap

ownership_percentage

Risk Factors

  • No material risks identified from this routine passive stake filing
  • The filing contains a power of attorney document and standard boilerplate; no unusual provisions

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
77% bullish (35 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0002012383-26-003968
Document: Item_7.txt0002012383-26-003968
Document: 0002012383-26-003968-index-headers.html0002012383-26-003968
Document: 0002012383-26-003968-index.html0002012383-26-003968
Document: 0002012383-26-003968.txt0002012383-26-003968

Track record

16 reports on BMRN

Performance horizon

2 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +8.91% at T+60 after the Apr 27, 2026 report. 3 of 5 went positive at some point.

Filters
  1. Nov 4, 202612d ago SC 13G/A Neutral 3/10 Viewing Entry $56.12 to $56.70 Now $57.99 +3.33% ▲ +1.03% −2.26% vs SPY
  2. Nov 2, 202614d ago 8-K Bearish 6/10 Entry $55.66 to $57.13 Now $57.99 −4.19% ▼ −2.64% −3.23% vs SPY
  3. Oct 29, 202618d ago Institutional Cluster Neutral 2/10 Entry $57.49 to $56.12 Now $57.99 +0.87% ▼ −2.38% +2.34% vs SPY
  4. Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $56.00 to $57.13 Now $57.99 +3.55% ▲ +2.02% +2.73% vs SPY
  5. Oct 6, 20265w ago 8-K Bearish 6/10 Entry $55.20 to $55.14 Now $57.99 −5.05% ▲ +0.11% −0.87% vs SPY
  6. Sep 15, 20268w ago 8-K Neutral 4/10 Entry $64.45 to $63.94 Now $57.99 −10.02% ▼ −0.79% −1.61% vs SPY
  7. Sep 14, 20269w ago 8-K Neutral 2/10 Entry $66.41 to $64.06 Now $57.99 −12.68% ▼ −3.54% −3.65% vs SPY
  8. Sep 1, 202610w ago 8-K Neutral 3/10 Entry $64.84 to $64.41 Now $57.99 −10.56% ▼ −0.66% −0.74% vs SPY
  9. Sep 1, 202610w ago Press Release Neutral 4/10 Entry $64.84 to $64.41 Now $57.99 −10.56% ▼ −0.66% −0.74% vs SPY
  10. Aug 31, 202611w ago 8-K Bullish 6/10 Entry $65.23 to $64.63 Now $57.99 −11.10% ▼ −0.92% −0.78% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens in 8h 2m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 4, 2026